They also help lower blood pressure and reduce heart disease risk
Research-grade peptides may contain impurities, degraded compounds, or incorrect concentrations, all of which can reduce effectiveness, shorten the duration of benefits, or even cause adverse reactions
NICEs 2025 guidance calls this dual-agonist action, the first of its kind approved in the UK
Insurance coverage remains inconsistent, and out-of-pocket costs for branded versions exceed $1,000 monthly for many patients, creating an affordability crisis even when medications are in stock
Read Time: 16 min read Ozempic and other GLP-1 drugs have changed the treatment landscape for diabetes and obesity
This is physician-guided optimization, not just a prescription